hepatitis C virus therapy (Gilead/BioTie)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehepatitis C virus therapy (Gilead/BioTie)
Drug Alias NameHCV therapy (Gilead/4 AZA)hepatitis C virus therapy (Gilead/4 AZA)HCV therapy (Gilead/elbion)hepatitis C virus therapy (Gilead/elbion)ELB-HCV +[6] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesWestern Europe
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator Companies4 AZA Bioscience NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotie Therapies Corp4 AZA Bioscience NVElbion Nv +[4] 
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A